Cargando…

Recent progress in the treatment of multiple myeloma: updates and highlights from ASH 2008

Detalles Bibliográficos
Autor principal:	Jagannath, Sundar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322490/ http://dx.doi.org/10.1186/1756-8722-2-S1-A4

Ejemplares similares

ASH Highlights and Commentary: Multiple Myeloma
Publicado: (2022)

ASH Highlights and Commentary: Multiple Myeloma
Publicado: (2021)

Recent advances in myelodysplasia: update from 2011 ASH annual meeting
por: Liu, Delong
Publicado: (2012)

Updates on Therapeutic Advancements in Relapsed or Refractory Multiple Myeloma: Highlights From SOHO 2020
Publicado: (2021)

Recent Advances in the Understanding and Treatment of Multiple Myeloma
por: Cook, Richard, et al.
Publicado: (2008)

ASH Highlights and Commentary: Myeloid Malignancies
Publicado: (2022)

Recent Advances in the Treatment Of Newly Diagnosed Multiple Myeloma
por: Libby, Edward, et al.
Publicado: (2020)

T-cell immunodeficiency and reconstruction based on TCR rearrangement analysis in hematological malignancy: update from 2011 ASH annual meeting
por: Li, Yangqiu
Publicado: (2012)

ASH Highlights and Commentary: Additional Topics of Interest
Publicado: (2022)

ASH Highlights and Commentary: Additional Topics of Interest
Publicado: (2021)

Bispecific antibody treatment of multiple myeloma: latest updates from the 2022 ASH annual meeting
por: Yin, Xuejiao, et al.
Publicado: (2023)

ASH Highlights and Commentary: Chronic Lymphocytic Leukemia and Lymphomas
Publicado: (2021)

BCMA-Directed CAR T Cells in Relapsed Refractory Multiple Myeloma: Highlights From SOHO 2021
Publicado: (2022)

Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium
por: Tefferi, A, et al.
Publicado: (2011)

Update of recent studies in chronic myeloid leukemia
por: Seiter, Karen
Publicado: (2009)

Targeting BCMA to Treat Multiple Myeloma: Updates From the 2021 ASH Annual Meeting
por: Guo, Ruiting, et al.
Publicado: (2022)

Recent progress in thyroid surgery
por: Dedecjus, Marek
Publicado: (2013)

Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference
por: Ebner, Nicole, et al.
Publicado: (2012)

Pathophysiological Underpinnings of Multiple Myeloma Progression
por: Jagannath, Sungar
Publicado: (2008)

Targeting p53 by small molecule p53 activators in multiple myeloma
por: Saha, Manujendra N, et al.
Publicado: (2012)

Therapeutic Updates for Richter Syndrome: Highlights From SOHO 2021
Publicado: (2022)

Updates on Clinical Trials for Myelofibrosis: Highlights From SOHO 2021
Publicado: (2022)

MM-239: A Tertiary Center Experience of Multiple Myeloma Patients with COVID-19: Lessons Learned and the Path Forward
por: Wang, Bo, et al.
Publicado: (2020)

Epidemiological profile of diabetics who died in Brazil from 2008 to 2012
por: de Oliveira Naliato, Erika Cesar, et al.
Publicado: (2015)

Proteasome inhibition and its therapeutic potential in multiple myeloma
por: Chari, Ajai, et al.
Publicado: (2010)

Hematopoietic stem cell transplantation in Multiple Myeloma. Experience of the Instituto Nacional de Cancerologia, Mexico
por: Bahena-Garcia, Magdalena, et al.
Publicado: (2007)

Abstracts of Papers Presented at the 2008 Pittsburgh Conference
por: Stockwell, Peter B.
Publicado: (2008)

What's new in the management of chronic lymphocytic leukemia? 2008 ASH Review (New York Medical College, January 31, 2009)
por: Maddocks, Kami J, et al.
Publicado: (2009)

Recent updates on CAR T clinical trials for multiple myeloma
por: Lin, Quande, et al.
Publicado: (2019)

Hospital reimbursement and readmissions. Norway 2002, 2005 and 2008
por: Petersen, S O
Publicado: (2010)

Impact of COVID-19 on Treatment Patterns and Management of Multiple Myeloma: Insights from the Connect® MM Registry
por: Richter, Joshua, et al.
Publicado: (2022)

Early treatment of recent-onset rheumatoid arthritis patients impairs the effect of HLA class II antigents on the progression of joint destruction
por: Lard, LR, et al.
Publicado: (2001)

Experiences in psychosocial support in disaster situations from developing countries: the Ica - Peru earthquakes of 2008
por: Tarev, Alexander A, et al.
Publicado: (2010)

Update from New Zealand
por: Mitchell, Edwin A
Publicado: (2015)

MHC class II deficiency in the Dene native population: a case report highlighting pitfalls in diagnosis and treatment
por: Lyttle, Alex, et al.
Publicado: (2014)

Novel Treatments for Patients With Relapsed/Refractory Multiple Myeloma
por: Rodriguez, Cesar, et al.
Publicado: (2023)

Highlights from the Third European International Society for Computational Biology (ISCB) Student Council Symposium 2014
por: Francescatto, Margherita, et al.
Publicado: (2015)

What Affects Treatment Underuse in Multiple Myeloma in the United States: A Qualitative Study
por: Cytryn, Rose, et al.
Publicado: (2023)

Hospitalizations due to diabetes mellitus from January/2008 to February/2015 in Brazil – a datasus based report
por: de Oliveira Naliato, Erika Cesar, et al.
Publicado: (2015)

Economics of diabetes mellitus: evidence of the disease's social cost for Brazilian data in 2008
por: Wiest, Ramon, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3h9ba13mkk772lop7gmmenn32n